Bayesian Capital Management, LP Pa Vmed Inc. Transaction History

Bayesian Capital Management, LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.41 $34,935 - $57,951	-41,100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.16 - $2.5 $47,676 - $102,750	41,100 New	41,100 $54,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.